Performance Review Board Members, 47619 [2018-20445]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 183 / Thursday, September 20, 2018 / Notices
47619
**** The research team anticipates grading all outcomes but if needed (based on the volume of evidence), they may seek input from the TEP
on prioritizing outcomes for strength of evidence grading.
AE = adverse event; BDI = Beck Depression Inventory; CAS: The Child Assessment Schedule; CBT = cognitive behavioral therapy; CCT =
controlled clinical trial; CIDI = Composite International Diagnostic Interview; CDI = Children’s Depression Inventory; CES–D = Center for Epidemiological Studies Depression Scale; ChilD–S: Children’s Depression Screener; DAWBA = The Development and Wellbeing Assessment; DD =
dysthymic disorder; DICA = Diagnostic Interview for Children and Adolescents; DISC = Diagnostic Interview Schedule for Children; DSM = Diagnostic and Statistical Manual; IPT = interpersonal therapy; Kinder-DIPS = The Diagnostic Interview for Psychiatric Disorders in Children and Adolescents; K–SADS = The Schedule for Affective Disorders and Schizophrenia for School-Age Children; MDD = major depressive disorder; MFQ =
Mood and Feelings Questionnaire; PDD = persistent depressive disorder; PHQ = Patient Health Questionnaire; PICOTS = populations, interventions, comparators, outcomes, timing, and setting; PRIME–MD = The Primary Care Evaluation of Mental Disorders; RCT = randomized controlled
trial; SADS = The Schedule for Affective Disorders and Schizophrenia; SCAN = Schedules for Clinical Assessment in Neuropsychiatry; SCID =
Structured Clinical Interview for DSM disorders.
References
1. Roseman M, Kloda LA, Saadat N, et al.
Accuracy of Depression Screening Tools
to Detect Major Depression in Children
and Adolescents: A Systematic Review.
Can J Psychiatry. 2016 Dec;61(12):746–
57. doi: 10.1177/0706743716651833.
PMID: 27310247.
2. Stockings E, Degenhardt L, Lee YY, et al.
Symptom screening scales for detecting
major depressive disorder in children
and adolescents: a systematic review and
meta-analysis of reliability, validity and
diagnostic utility. J Affect Disord. 2015
Mar 15;174:447–63. doi: 10.1016/
j.jad.2014.11.061. PMID: 25553406.
Francis D. Chesley, Jr.,
Deputy Director.
CDC Performance Review Boards or
Panels, which will oversee the
evaluation of performance appraisals of
Senior Executive Service members for
the Fiscal Year 2018 review period:
Dean, Hazel Co-Chair
Shelton, Dana Co-Chair
Arispe, Irma
Boyle, Coleen
Branche, Christine
Curlee, Robert C.
Kosmos, Christine
Peeples, Amy
Qualters, Judith
Ruiz, Roberto
Smagh, Kalwant
Dated: September 17, 2018.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2018–20481 Filed 9–19–18; 8:45 am]
BILLING CODE 4160–90–P
[FR Doc. 2018–20445 Filed 9–19–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Performance Review Board Members
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) is publishing the
names of the Performance Review Board
Members who are reviewing
performance for Fiscal Year 2018.
FOR FURTHER INFORMATION CONTACT:
Sandra DeShields, Chief, Compensation
and Performance Management Team,
Executive and Scientific Resources
Office, Human Resources Office, Centers
for Disease Control and Prevention, 11
Corporate Square Blvd., Mailstop US11–
2, Atlanta, Georgia 30341, Telephone
(770) 488–0252.
SUPPLEMENTARY INFORMATION: Title 5,
U.S.C. Section 4314(c)(4) of the Civil
Service Reform Act of 1978, Public Law
95–454, requires that the appointment
of Performance Review Board Members
be published in the Federal Register.
The following persons will serve on the
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:01 Sep 19, 2018
Jkt 244001
[CMS–4184–N]
Medicare Program; Medicare Appeals;
Adjustment to the Amount in
Controversy Threshold Amounts for
Calendar Year 2019
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
annual adjustment in the amount in
controversy (AIC) threshold amounts for
Administrative Law Judge (ALJ)
hearings and judicial review under the
Medicare appeals process. The
adjustment to the AIC threshold
amounts will be effective for requests
for ALJ hearings and judicial review
filed on or after January 1, 2019. The
calendar year 2019 AIC threshold
amounts are $160 for ALJ hearings and
$1,630 for judicial review.
DATES: This annual adjustment is
effective for requests for ALJ hearings
and judicial review filed on or after
January 1, 2019.
SUMMARY:
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
Liz
Hosna (Katherine.Hosna@cms.hhs.gov),
(410) 786–4993.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Background
Section 1869(b)(1)(E) of the Social
Security Act (the Act), as amended by
section 521 of the Medicare, Medicaid,
and SCHIP Benefits Improvement and
Protection Act of 2000 (BIPA),
established the amount in controversy
(AIC) threshold amounts for
Administrative Law Judge (ALJ)
hearings and judicial review at $100 and
$1,000, respectively, for Medicare Part
A and Part B appeals. Section 940 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA), amended section
1869(b)(1)(E) of the Act to require the
AIC threshold amounts for ALJ hearings
and judicial review to be adjusted
annually. Beginning in January 2005,
the AIC threshold amounts are to be
adjusted by the percentage increase in
the medical care component of the
consumer price index (CPI) for all urban
consumers (U.S. city average) for July
2003 to July of the year preceding the
year involved and rounded to the
nearest multiple of $10. Section
940(b)(2) of the MMA provided
conforming amendments to apply the
AIC adjustment requirement to
Medicare Part C/Medicare Advantage
(MA) appeals and certain health
maintenance organization and
competitive health plan appeals. Health
care prepayment plans are also subject
to MA appeals rules, including the AIC
adjustment requirement. Section 101 of
the MMA provides for the application of
the AIC adjustment requirement to
Medicare Part D appeals.
A. Medicare Part A and Part B Appeals
The statutory formula for the annual
adjustment to the AIC threshold
amounts for ALJ hearings and judicial
review of Medicare Part A and Part B
appeals, set forth at section
1869(b)(1)(E) of the Act, is included in
the applicable implementing
regulations, 42 CFR 405.1006(b) and (c).
The regulations require the Secretary of
Health and Human Services (the
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 83, Number 183 (Thursday, September 20, 2018)]
[Notices]
[Page 47619]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20445]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Performance Review Board Members
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) located
within the Department of Health and Human Services (HHS) is publishing
the names of the Performance Review Board Members who are reviewing
performance for Fiscal Year 2018.
FOR FURTHER INFORMATION CONTACT: Sandra DeShields, Chief, Compensation
and Performance Management Team, Executive and Scientific Resources
Office, Human Resources Office, Centers for Disease Control and
Prevention, 11 Corporate Square Blvd., Mailstop US11-2, Atlanta,
Georgia 30341, Telephone (770) 488-0252.
SUPPLEMENTARY INFORMATION: Title 5, U.S.C. Section 4314(c)(4) of the
Civil Service Reform Act of 1978, Public Law 95-454, requires that the
appointment of Performance Review Board Members be published in the
Federal Register. The following persons will serve on the CDC
Performance Review Boards or Panels, which will oversee the evaluation
of performance appraisals of Senior Executive Service members for the
Fiscal Year 2018 review period:
Dean, Hazel Co-Chair
Shelton, Dana Co-Chair
Arispe, Irma
Boyle, Coleen
Branche, Christine
Curlee, Robert C.
Kosmos, Christine
Peeples, Amy
Qualters, Judith
Ruiz, Roberto
Smagh, Kalwant
Dated: September 17, 2018.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2018-20445 Filed 9-19-18; 8:45 am]
BILLING CODE 4163-18-P
